Ping An Biomedical Co., Ltd.

$0.17 ▼ -1.57%
2026-04-21 08:44:01

Explore Ping An Biomedical Co., Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$4.08 M
Current Price
$0.17
52W High / Low
$5.4 / $0.12
Stock P/E
Book Value
$0.32
Dividend Yield
ROCE
-32.43%
ROE
-67.43%
Face Value
EPS
$-0.1
Exp Qtr EPS
Sector
Consumer Cyclical
Industry
Textile Manufacturing
Employees
7
Beta
Debt / Equity
23.14
Current Ratio
2.76
Quick Ratio
2.74
Forward P/E
Price / Sales
0.55
Enterprise Value
$13 M
EV / EBITDA
-0.89
EV / Revenue
0.38
Rating
None
Target Price
EPS Forecast (FY)

Pros

  • Balance sheet leverage appears manageable.
  • Short-term liquidity looks comfortable.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Operating margin is thin.
  • Net margin is relatively low.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Albany International Corp. $58.39 $1.65 B 1.92% -1.76% -6.78% $73 / $41.15 $25.66
2. SMJ International Holdings Inc. $3.19 $7 / $0.82 $0.25
3. Culp, Inc. $3.02 $38.24 M -13.92% -18.28% $4.8 / $2.7 $3.97
4. Unifi, Inc. $3.73 $68.85 M -11.34% -9.58% $5.68 / $2.96 $12.38
5. Capital One Financial Corporation $201.85 60.17 $129.08 B 1.56% 2.39% $259.63 / $158.42 $173.11
6. Adobe Inc. $256.01 14.95 $103.64 B 45.12% 58.77% $422.95 / $224.13 $28.16
7. The Boeing Company $225.35 91 $177.82 B 0.19% -9.01% 2.9% $254.35 / $156.47 $6.94

Quarterly Results

Figures shown in M / B

Sales
Operating Profit
Net Profit
EPS in Rs

Profit & Loss

Figures shown in M / B

2025202420232022
Sales34.15 M87.62 M82.56 M114.55 M
Operating Profit-14.7 M-0 M0.61 M11.15 M
Net Profit-12.83 M-1.28 M-0.99 M7.23 M
EPS in Rs-0.1-0.01-0.010.06

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets68.41 M56.85 M79.84 M81.95 M
Total Liabilities23.17 M64.04 M85.7 M77.35 M
Equity45.24 M-7.19 M-5.86 M4.6 M
Current Assets63.7 M53.31 M76.57 M79.04 M
Current Liabilities23.08 M63.58 M85.63 M77.35 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF-6.43 M14.63 M-6.08 M21.09 M
Investing CF0 M15 M-3.37 M-30.26 M
Financing CF43.66 M-30.09 M8.87 M10.24 M
Free CF-6.43 M14.63 M-6.08 M21.06 M
Capex-0.02 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

2024202320222021
Revenue Growth %6.13%-27.92%
Earnings Growth %-29.2%-113.75%
Profit Margin %-1.47%-1.2%6.31%
Operating Margin %-0%0.74%9.73%
Gross Margin %6.18%5.14%12.35%
EBITDA Margin %0.54%2.2%10.13%

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

No dividend history available.

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund Mutual Fund 0.01 M $0 M 0% 2026-02-28
Xtx Topco Ltd Institutional 0.02 M $0 M 0% 2025-12-31
Citadel Advisors Llc Institutional 0.02 M $0 M 0% 2025-12-31
UBS Group AG Institutional 0 M $0 M 0% 2025-12-31